OptraScan wins patent for digital pathology AI technology

By LabPulse.com staff writers

May 25, 2022 -- OptraScan has received a U.S. patent for technology on its OS-SiA digital pathology scanner, which is able to scan, index, and analyze pathological samples simultaneously.

U.S. Patent No. 2020/0334814 A1 details technology that identifies pathology specimens to scan and then simultaneously analyzes the tissue or cell area being scanned, according to the company. OptraScan's artificial intelligence (AI)-based digital pathology scanner enables end users to view the scanned whole-side image along with analyzed output as an overlay during the review process, the firm said.

Digital pathology: What does the future hold?
It's no secret that digital pathology's efforts to integrate itself into clinical diagnosis have been met with difficulty in recent years. But what does...
OptraScan, Inspirata to partner
OptraScan and Inspirata plan to partner to help pathology labs, healthcare networks, and hospitals better access digital pathology images.
OptraScan launches cytology slide scanning device
OptraScan has released a new device called CytoSiA for scanning and analyzing liquid-based cytology slides and Pap smears.
OptraScan launches new scanner
OptraScan announced it has launched a high-speed scanner called the OS-Ultra 320 designed to reduce workflow errors and scale up pathology laboratory...

Copyright © 2022 LabPulse.com

Last Updated mp 5/25/2022 7:06:24 AM